4 reports

THREATS OF SUBSTITUTES - LOW ##.

  • Cardiovascular Devices
  • Injectable Delivery
  • World
  • Market Size
  • Edwards Lifesciences Corporation

THE COMPANY' S NEUROMODULATION SEGMENT PROVIDES VAGUS NERVE STIMULATION THERAPY SYSTEM, AN IMPLANTABLE DEVICE FOR THE PEOPLE AFFECTED BY TREATMENT-RESISTANT EPILEPSY, DEPRESSION, HEART FAILURE AND OTHER CHRONIC DISORDERS.

  • Cardiac Management
  • Injectable Delivery
  • Peripheral Vascular Device
  • Prosthesis
  • Edwards Lifesciences Corporation

THE COMPANY' S NEUROMODULATION SEGMENT PROVIDES VAGUS NERVE STIMULATION THERAPY SYSTEM, AN IMPLANTABLE DEVICE FOR THE PEOPLE AFFECTED BY TREATMENT-RESISTANT EPILEPSY, DEPRESSION, HEART FAILURE AND OTHER CHRONIC DISORDERS.

  • Immunotherapy
  • Injectable Delivery
  • Prosthesis
  • Italy
  • Edwards Lifesciences Corporation

OBESITY IT IS THE LEADING RISK FACTOR GIVING RISE TO OTHER ILLNESSES SUCH AS TYPE ## DIABETES, CARDIOVASCULAR DISEASE, AND DEPRESSION.

  • Cardiology
  • Injectable Delivery
  • World
  • Market Size
  • Edwards Lifesciences Corporation